We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Extra Centrosomes Cause Cancer Cell Chromosomal Instability

By LabMedica International staff writers
Posted on 18 Jun 2009
Cancer cell biologists have identified a molecular mechanism that explains why many of the cells that make up a tumor contain an abnormal number of chromosomes.

While it seemed reasonable to link the abnormal number of chromosomes (known as chromosomal instability [CIN]) in cancer cells to the presence of extra centrosomes, a direct mechanistic link between extra centrosomes and CIN was never established. More...
The consensus has been that extra centrosomes generate CIN by promoting multipolar anaphase, a highly abnormal division that produces three or more aneuploid daughter cells.

In the current study, investigators from the Dana-Farber Cancer Institute (Boston, MA, USA) used long-term live-cell imaging to demonstrate that cells with multiple centrosomes rarely underwent multipolar cell divisions, and the progeny of these divisions were typically unable to survive. Thus, CIN could not be explained by the multipolar divisions theory.

In the June 7, 2009, online edition of the journal Nature the investigators published results from a study designed to identify the mechanism underlying the cancer cells' mitotic defect. To this end, they generated cells that differed only in their centrosome number. They demonstrated that extra centrosomes alone were sufficient to promote chromosome missegregation during bipolar cell division. These segregation errors were a consequence of cells passing through a transient "multipolar spindle intermediate” in which microtubule attachment errors accumulated before centrosome clustering and anaphase. These findings showed a direct mechanistic link between extra centrosomes and CIN, two common characteristics of solid tumors.

"We showed that even though most cancer cells with extra centrosomes form a single mitotic spindle, they pass through a brief "multipolar spindle” stage,” said first author Dr. Neil Ganem, a postdoctoral fellow at the Dana-Farber Cancer Institute. "The presence of this unique spindle configuration causes a few chromosomes to attach improperly to the eventual two-ended spindle. That, in turn, disrupts the normally orderly process by which chromosomes are pulled into the daughter cells.”

"Chromosome instability is a hallmark of most cancer cells, arising when chromosomes are missegregated into daughter cells during division,” said Dr. Ganem. "Such instability may be a double-edged sword. It may confer a survival benefit on cancer cells by enabling them to adapt to a stressful environment in the body or by helping them become resistant to chemotherapy drugs. But it may also have deleterious effects that could make tumor cells susceptible to therapeutic attack.”

Related Links:

Dana-Farber Cancer Institute




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.